Daclizumab phase II trial in relapsing and remitting multiple sclerosis
John Rose(VA Salt Lake City Healthcare System), Noel G. Carlson(VA Salt Lake City Healthcare System), Johan Björklund(Karolinska University Hospital), Hilary E. Watt(Geriatric Research Education and Clinical Center), JaneC Burns(Geriatric Research Education and Clinical Center), J. Klein(Geriatric Research Education and Clinical Center)
Cited by 161
Related Papers
Dispatch of Firefighters and Police Officers in Out‐of‐Hospital Cardiac Arrest: A Nationwide Prospective Cohort Trial Using Propensity Score Analysis
|Journal of the American Heart Association|2017|62
Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery
|Prostate Cancer and Prostatic Diseases|2018|43
Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death
|Journal of Neuroinflammation|2010|40
Risk of Venous Thromboembolic Events After Surgery for Cancer
|JAMA Network Open|2024|38
Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts
|Respiratory Research|2013|36